Rockwell Medical Launches Convenience Pack to Support Home Hemodialysis and Acute Dialysis Facilities
07 8월 2024 - 7:00PM
Business Wire
Two 1-gallon pre-mixed containers of
hemodialysis concentrates products CitraPure, RenalPure, or
SteriLyte offer easier handling and streamlined workflow for
patients, caregivers and healthcare providers
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a
healthcare company that develops, manufactures, commercializes, and
distributes a portfolio of hemodialysis products to dialysis
providers worldwide, today announced that it has launched a
Convenience Pack, which includes two 1-gallon pre-mixed containers
of one of the Company's hemodialysis concentrate products
CitraPure®, RenalPure®, or SteriLyte®, offering a number of
advantages for home patients and acute facilities.
"We are excited to offer home hemodialysis patients and acute
care facilities a new, more ergonomic packaging option that is more
accessible and easier to handle," said Tim Chole, Chief Commercial
Officer at Rockwell Medical. "There is a patient-centric movement
to drive dialysis treatments into the home to reduce the cost and
complexity of dialysis treatments, all the while transforming the
dialysis experience for patients. Rockwell is excited to become a
critical player in the at-home market to support hemodialysis
patients and their journey to take control over their time and
treatments."
Rockwell Medical provides the hemodialysis community with
high-quality products regulated by the U.S. Food and Drug
Administration (FDA), reliable delivery services, and a robust
Quality Management System. The Company is ISO 13485 Certified and
adheres to current Good Manufacturing Practices (cGMP) and
Association for Advancement of Medical Instrumentation (AAMI)
standards. Rockwell manufactures a full suite of products including
Citric Acid Concentrate Powders and Liquids; Acetic Acid
Concentrate Powders and Liquids; Bicarbonate Concentrate Powders
and Liquids; and Product Mixer, Cleaners and Accessories. For more
information about Rockwell Medical's Convenience Pack, or to learn
how you can include a Convenience Pack on your next order, please
contact Rockwell Medical's Sales Team at
www.rockwellmed.com/contact.
About Rockwell Medical Rockwell Medical, Inc. (Nasdaq:
RMTI) is a healthcare company that develops, manufactures,
commercializes, and distributes a portfolio of hemodialysis
products for dialysis providers worldwide. Rockwell Medical's
mission is to provide dialysis clinics and the patients they serve
with the highest quality products supported by the best customer
service in the industry. Rockwell is focused on innovative,
long-term growth strategies that enhance its products, its
processes, and its people, enabling the Company to deliver
exceptional value to the healthcare system and provide a positive
impact on the lives of hemodialysis patients. Hemodialysis is the
most common form of end-stage kidney disease treatment and is
typically performed at freestanding outpatient dialysis centers,
hospital-based outpatient centers, skilled nursing facilities, or
in a patient’s home. Rockwell Medical's products are vital to
vulnerable patients with end-stage kidney disease, and the Company
is relentless in providing unmatched reliability and customer
service. Rockwell Medical is the second largest supplier of acid
and bicarbonate concentrates for dialysis patients in the United
States and has the vision of becoming the leading global supplier
of hemodialysis concentrates. Certified as a Great Place to Work®
in 2023 and 2024, Rockwell Medical is Driven to Deliver
Life-Sustaining Dialysis Solutions™. For more information, visit
www.RockwellMed.com.
Forward-Looking Statements Certain statements in this
press release may constitute "forward-looking statements" within
the meaning of the federal securities laws. Words such as, "may,"
"might," "will," "should," "believe," "expect," "anticipate,"
"estimate," "continue," "could," "can," "would," "develop," "plan,"
"potential," "predict," "forecast," "project," "intend," "look
forward to," "remain confident," “are determined,” “are on track,”
“are resolute in our vision,” or the negative of these terms, and
similar expressions, or statements regarding intent, belief, or
current expectations, are forward looking statements. There can be
no assurance that Rockwell Medical will become the leading global
supplier of hemodialysis concentrates. While Rockwell Medical
believes these forward-looking statements are reasonable, undue
reliance should not be placed on any such forward-looking
statements, which are based on information available to us on the
date of this release. These forward-looking statements are based
upon current estimates and assumptions and are subject to various
risks and uncertainties (including, without limitation, those set
forth in Rockwell Medical's SEC filings), many of which are beyond
our control and subject to change. Actual results could be
materially different. Risks and uncertainties include, but are not
limited to those risks more fully discussed in the "Risk Factors"
section of our Annual Report on Form 10-K for the year ended
December 31, 2023, as such description may be amended or updated in
any future reports we file with the SEC. Rockwell Medical expressly
disclaims any obligation to update our forward-looking statements,
except as may be required by law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240807907576/en/
Heather R. Hunter SVP, Chief Corporate Affairs Officer (248)
432-1362 IR@RockwellMed.com
Rockwell Medical (NASDAQ:RMTI)
과거 데이터 주식 차트
부터 9월(9) 2024 으로 10월(10) 2024
Rockwell Medical (NASDAQ:RMTI)
과거 데이터 주식 차트
부터 10월(10) 2023 으로 10월(10) 2024